The Russian Federation has witnessed a marked rise in rates of tuberculosis (TB) over the past decade. Public health TB control institutions remain broadly modelled along pre-1990 lines despite substantial programmes of investment and advocacy in implementing the World Health Organization's 'Directly Observed Treatment--short course' (DOTS) strategy. In 2002, we undertook a qualitative study to explore health care providers' perceptions of existing barriers to access to TB services in Samara Oblast in Russia. Six focus group discussions were conducted with physicians and nurses from facilities in urban and rural areas. Data were analyzed using a framework approach for applied policy research. Barriers to access to care were identified in in...
SETTING: Five in-patient and out-patient tuberculosis (TB) care facilities in two regions of Russia....
Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, killing nearly two millio...
Funding: The study was funded by the European and Developing Countries Clinical Trials Partnership (...
The Russian Federation has witnessed a marked rise in rates of tuberculosis (TB) over the past decad...
OBJECTIVE: The aim of this study was to describe health system challenges faced by tuberculosis (TB)...
SETTING: Samara Oblast, Russia. OBJECTIVE: To compare the rates of tuberculosis (TB) in health care ...
OBJECTIVES: To determine risk factors for pulmonary tuberculosis in Russia. DESIGN: Case-control stu...
Summary Tuberculosis disproportionately affects hard-to-reach populations, such as homeless people, ...
From PLOS via Jisc Publications Router.History: collection 2018, received 2018-01-24, accepted 2018-...
The Russian Federation has the eleventh highest tuberculosis burden in the world in terms of the tot...
BACKGROUND: Vulnerable individuals with tuberculosis (TB) struggle to access and stay on treatment. ...
IntroductionPatients with Tuberculosis (TB) still have barriers in accessing high quality care and t...
Tuberculosis remains a leading cause of death worldwide. Transmission is the dominant mechanism sust...
Introduction: Tuberculosis is a major public health condition worldwide. The partnership between Hea...
BACKGROUND: The World Health Organisation (WHO) defines Russia as one of the 22 highest-burden count...
SETTING: Five in-patient and out-patient tuberculosis (TB) care facilities in two regions of Russia....
Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, killing nearly two millio...
Funding: The study was funded by the European and Developing Countries Clinical Trials Partnership (...
The Russian Federation has witnessed a marked rise in rates of tuberculosis (TB) over the past decad...
OBJECTIVE: The aim of this study was to describe health system challenges faced by tuberculosis (TB)...
SETTING: Samara Oblast, Russia. OBJECTIVE: To compare the rates of tuberculosis (TB) in health care ...
OBJECTIVES: To determine risk factors for pulmonary tuberculosis in Russia. DESIGN: Case-control stu...
Summary Tuberculosis disproportionately affects hard-to-reach populations, such as homeless people, ...
From PLOS via Jisc Publications Router.History: collection 2018, received 2018-01-24, accepted 2018-...
The Russian Federation has the eleventh highest tuberculosis burden in the world in terms of the tot...
BACKGROUND: Vulnerable individuals with tuberculosis (TB) struggle to access and stay on treatment. ...
IntroductionPatients with Tuberculosis (TB) still have barriers in accessing high quality care and t...
Tuberculosis remains a leading cause of death worldwide. Transmission is the dominant mechanism sust...
Introduction: Tuberculosis is a major public health condition worldwide. The partnership between Hea...
BACKGROUND: The World Health Organisation (WHO) defines Russia as one of the 22 highest-burden count...
SETTING: Five in-patient and out-patient tuberculosis (TB) care facilities in two regions of Russia....
Tuberculosis (TB) is a leading cause of morbidity and mortality worldwide, killing nearly two millio...
Funding: The study was funded by the European and Developing Countries Clinical Trials Partnership (...